Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 10 relevant journals, 15 Conferences, 30 workshops are presently dedicated exclusively to breathing disorder and about 2,070 articles are being published on Palliative Care
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Palliative Care is a zone of health care that keeps tabs on assuaging and anticipating the enduring of patients. Unlike hospice mind, palliative medication is suitable for patients in all sickness stages, incorporating those experiencing medicine for reparable ailments and those living with unending infections, and in addition patients who are nearing the close of life. Palliative prescription uses a multidisciplinary approach to patient forethought, depending on data from doctors, drug specialists, nurture, clerics, social laborers, analysts and other associated health experts in planning an arrangement of consideration to ease enduring in every aspect of a patient's existence. This multidisciplinary approach permits the palliative forethought group to address physical, passionate, otherworldly and social worries that emerge with progressed disease. Medications and medications are said to have a palliative impact in the event that they diminish side effects without having a remedial impact on the underlying infection or cause. This can incorporate treating queasiness identified with chemotherapy or something as straightforward as morphine to treat the ache of broken leg or ibuprofen to treat yearning identified with a flu tainting. In spite of the fact that the notion of palliative forethought is not new, most medical practitioners have generally focused on attempting to cure patients. Medicines for the easing of side effects were seen as risky and seen as welcoming fixation and other unwanted side effects. The focus on a patient's personal satisfaction has expanded significantly throughout the previous twenty years. In the United States today, 55% of clinics with more than 100 mattresses offer a palliative-mind program, and about one-fifth of group healing centers have palliative-mind programs. A generally later improvement is the palliative-mind group, a devoted social insurance group that is actually intended for palliative medication. Scope of Palliative care: A World Health Organisation statement depicts palliative care thought as "a methodology that enhances the personal satisfaction of patients and their families confronting the issues connected with life-undermining disease, through the avoidance and help of enduring by method of unanticipated recognizable proof and faultless appraisal and medication of agony and different issues, physical, psychosocial and otherworldly." More by and large, in any case, the expression "palliative consideration" might allude to any forethought that mitigates indications, whether there is any expectation of a cure by different implies; hence, palliative medicines may be utilized to assuage the symptoms of therapeutic medications, for example mitigating the queasiness connected with chemotherapy. • Provides help from ache, shortness of breath, sickness and other troubling indications • Affirms life and views passing on as an ordinary process • Integrates the mental and profound parts of patient forethought • Offers an emotionally supportive network to help patients live as eagerly as could be expected under the circumstances • Offers an emotionally supportive network to help the family Signs of Palliative care: Instantaneous palliative look after patients with any genuine disease and who have physical, mental, social, or otherworldly trouble as an aftereffect of the medicine they are looking for or receiving. Palliative consideration expands solace by reducing agony, regulating manifestations, and decreasing stretch for the patient and family, and ought not be postponed when it is indicated. Palliative forethought is not saved for patients in close of-life consideration and can expand personal satisfaction and protract the patient's existence. In some cases, medical specialty professional organizations recommend that patients and physicians respond to an illness only with palliative care and not with a therapy directed at the disease. The following items are indications named by the American Society of Clinical Oncology as characteristics of a patient who should receive palliative care but not any cancer-directed therapy. Practice of Palliative care: -Evaluation of symptoms A method for the assessment of symptoms in patients admitted to palliative care is the Edmonton Symptoms Assessment Scale (ESAS), in which there are eight visual analog scales (VAS) of 0 to 10, indicating the levels of pain, activity, nausea, depression, anxiety, drowsiness, appetite and sensation of well-being, sometimes with the addition of shortness of breath. On the scales, 0 means that the symptom is absent and 10 that it is of worst possible severity. It is completed either by the patient alone, by the patient with nurse's assistance, or by the nurses or relatives. -Symptom management Medications used for palliative patients are used differently than standard medications, based on established practices with varying degrees of evidence. Examples include the use of antipsychotic medications to treat nausea, anticonvulsants to treat pain, and morphine to treat dyspnea. Routes of administration may differ from acute or chronic care, as many patients lose the ability to swallow. A common alternative route of administration is subcutaneous, as it is less traumatic and less difficult to maintain than intravenous medications. Other routes of administration include sublingual, intramuscular and transdermal. Medications are often managed at home by family or nursing support. -Dealing with distress The key to effective palliative care is to provide a safe way for the individual to address their physical and psychological distress, that is to say their total suffering. Dealing with total suffering involves a broad range of concerns, starting with treating physical symptoms such as pain, nausea and breathlessness. The palliative care teams have become very skillful in prescribing drugs for physical symptoms, and have been instrumental in showing how drugs such as morphine can be used safely while maintaining a patient's full faculties and function. -Procurement of administrations Because palliative care sees an increasingly wide range of conditions in patients at varying stages of their illness it follows that palliative care teams offer a range of care. This may range from managing the physical symptoms in patients receiving treatment for cancer, to treating depression in patients with advanced disease, to the care of patients in their last days and hours. Much of the work involves helping patients with complex or severe physical, psychological, social and spiritual problems. In the US palliative care services can be offered to any patient without restriction to disease or prognosis. Hospice care under the Medicare Hospice Benefit, however, requires that two physicians certify that a patient has less than six months to live if the disease follows its usual course. This does not mean, though, that if a patient is still living after six months in hospice he or she will be discharged from the service. Such restrictions do not exist in other countries such as the United Kingdom. Physicians practicing palliative care do not always receive support from patients, family members, healthcare professionals or their social peers for their work to reduce suffering and follow patients' wishes for end-of-life care. More than half of physicians in one survey reported that a patient's family members, another physician or another health care professional had characterized their work as being "euthanasia, murder or killing" during the last five years. A quarter of them had received similar comments from their own friends or family member, or from a patient
Market Analysis:
Geographically, North America accounts for one of the largest markets followed by Europe. Baby boomers play a major role in the market growth. According to the U.S. Census Bureau, the average life expectancy in the U.S. will be 77.1 years for men and 81.9 years for women by 2020. To tackle the rising aging population, favorable reimbursement policies and extensive presence of care centers are set up to assist the problems faced by aged people. Asia Pacific is anticipated to be the fastest growing region due to the factors such as rise in persistent medical conditions and rising concern for life expectancies among the geriatric population. Latin America holds a strong potential for the market growth owing to the high presence of geriatric population and growing health care facility.
Some of the key players in this market segment are, the Jewish Family Service, the International Association of Geriatric Care, National Association of Professional Care Managers, Senior Care Centers, the UF health, the World Health Organization and others. These players constantly participate in awareness programs, as well as mergers and acquisitions to serve the elderly society effectively.
List of Best International Conferences
1. 3rd European Geriatrics Congress, June 20-21, 2016, Alicantae, Spain
2. 4th Geriatrics and Gerontology conference Aug 15-17, 2016 London, UK
3. Aging Conference, Aug 8-9, 2016 Las Vegas, USA
4. 5th Geriatric Medicine Conference Nov 17-19, 2016 Atlanta, USA
5. 4th Psychiatrist and Geriatric Psychiatry conference
6. 5th Alzheimer’s Disease and Dementia conference September 29-October 01, 2016 London, UK
7. 2nd Conference on Sleep Disorders and Medicine conference November 28-30, 2016 Chicago, USA
8. 2nd Parkinson’s Disease and Movement Disorders conference November 28-30, 2016 Seattle, USA
9. Rheumatology and Aging Conference 2015 08 - 11 Sep 2015,Cambridge, United Kingdom
10. IAGG Asia/Oceania 2015 — 19- 22 Oct 2015,Chiangmai, Thailand
11. 2015 American College of Rheumatology Annual Meeting 06- 11 Nov 2015,San Francisco, United States
12. Pro-Aging Europe Congress 2015 19 Nov -22 Nov 2015 Brussels, Belgium.
13. Ageing 2016 09- 11 Feb 2016, London, United Kingdom.
14. 4th World Parkinson Congress (WPC 2016), September 20-23, 2016, Portland.
15. World Congress on Active Ageing 2016, June 28/July 01/, 2016, Melbourne
16. International Federation on Ageing - 13th Global Conference: Disasters in an Ageing World - Readiness, Resilience and Recovery, June 21-23, 2016, Brisbane.
17. American Geriatrics Society Annual Scientific Meeting 2016, May 19-21, 2016, Long Beach
18. American Society on Aging (ASA) 2016 Aging in America Conference, March, 2016, Washington
19. 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy, March 20-24, 2016, Athens
20. AGHE‘s 42nd Annual Meeting and Educational Leadership Conference, March 9-12, 2016, Long Beach
21. Eastern Caribbean Cruise Conference 2016 - Palliative Medicine and End of Life Care: 2016 Update Including Related Topics in Neurology, February 14-21, 2016, Fort Lauderdale
Relevant Society and Associations
1. British Geriatrics Society
2. Canadian Geriatrics Society
3. Geriatric society of India
4. The Hong Kong Geriatrics Society
5. Oregon Geriatrics Society
6. European union Geriatric medicine society
Companies
1. Novartis
2. Pfizer
3. Roche
4. Sanofi
5. Merck & Co.
6. Johnson & Johnson
7. GlaxoSmithKline
8. AstraZeneca
9. Gilead Sciences
10. Takeda
11. AbbVie
12. Amgen
13. Teva
14. Lilly
15. Bristol-Myers Squibb
16. Bayer
17. Novo Nordisk
18. Astellas
19. BoehringerIngelheim
20. Actavis
21. Otsuka
22. Daiichi Sankyo
23. Biogen Idec
24. Baxter
25. Merck KGaA
This page will be updated regularly.
This page was last updated on November 25, 2024
